Skip to content
The Nexus
DossierENTITY

Hizentra

Coverage of Hizentra in the Nexus archive.

Earliest in view: Jun 29 · 09:00 UTCMost recent: Jun 29 · 09:00 UTC
Co-mentioned in this coverage
Margaret Hvatumperson1Humanaorganization1primary immunodeficiencytopic1prior authorizationtopic1Medicare Advantageorganization1
Recent coverage
  • HEALTHJun 29 · 09:00 UTCKFF HEALTH NEWS
    She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help

    Margaret Hvatum, a 70-year-old with primary immunodeficiency, faced insurance denials for her lifesaving drug Hizentra after switching Medicare Advantage plans, leading to health complications and denied hospital charges. The denial stemmed from prior authorization issues, a process that contributed to her hospitalization and financial burden.